Company intelligence / Profile preview

Henderson Morley

United Kingdomusa.businessdirectory.kwtbox.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Henderson Morley was a UK-based biotechnology company focused on the development of vaccines and antiviral therapies. The company underwent restructuring to become a pure-play vaccine business. It developed proprietary technologies such as Ionic ContraViral Therapy (ICVT) and engaged in collaborations for cancer vaccine research. The firm had ongoing divestment discussions regarding its portfolio around 2010, suggesting it wound down or sold off key assets rather than advancing them independently.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Vaccinesantiviral therapies
Industry: Biotech

Partnerships

Systems Biology Laboratory UK for cancer vaccine collaboration

Beyond the preview

Go deeper on Henderson Morley.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Henderson Morley.

Explore the full profile